Prior studies have shown that TGFBI enhances both EMT and proliferation via the PI3K/AKT/mTOR/HIF-1α pathway [47], and MUC15 promotes RCC metastasis by elevating phosphorylated AKT levels and increasing MMP2/MMP9 expression [48]. This evidence concerns the gene MTOR and renal cell carcinoma.